Celgene (NASDAQ:CELG)

biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
Test tubes

Top Biotechs Are Among Jefferies Growth Stock Favorites

One thing that has stretched multiples in the S&P 500 this year to a pricey 17 times earnings is that many people have chased a few stocks in the index ...
Read Full Story »
automatic inspection machine

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 29 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
money

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

The Nasdaq Biotechnology Index has underperformed the broader market for some time. This year the index is still down about 13%, versus the 6% rise for the S&P 500. We ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: Apollo Global, ADM, Celgene, Total, Whole Foods, Targa Resources and More

Stocks were indicated higher on Thursday after the Bank of England cut interest rates for the first time in seven years and engaged in more aggressive quantitative easing than expected. ...
Read Full Story »
buy now

RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains

We have talked about it for months here at 24/7 Wall St., and now many on Wall Street are talking about it as well. The selling in biotech, much of ...
Read Full Story »
clinical trials

How Celgene Won With This Earnings Report

Celgene Corp. (NASDAQ: CELG) reported its second-quarter financial results before the markets opened on Thursday. This company has an outstanding partnered pipeline, which most think is low risk and has ...
Read Full Story »
Test tubes

JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now

We have noted recently that large pharmaceuticals and biotech have been hammered, and now may be offering outstanding total return potential. While the larger pharmaceutical stocks have done better recently, the ...
Read Full Story »
biotech word cloud

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
Profit or Loss

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We are in the heart of earnings season, in which ...
Read Full Story »
biotech word cloud

Short Sellers Become More Selective on Major Biotechs

The short interest data are out for the June 30 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. In ...
Read Full Story »
Pills and tablets

Biotechs With Drug Pipelines Closest to Zero Valuation

As biotech valuations and share price remain muted versus historic trends, investors have been evaluating which of the best biotech companies are offering the most upside. Other investors are looking ...
Read Full Story »
Money and plant

Jefferies Has Top Growth Stocks to Buy for the Rest of 2016

After a stunning rally off the lows caused by the Brexit, it looks as though the market feels a little tired. Tuesday's selling, while calm, shows that investors are still ...
Read Full Story »
automatic inspection machine

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health ...
Read Full Story »